Powala Christopher
Insider CIK 1654301 · ACRS Chief Reg & Develop Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2019-02-01 | 2019-02-05 | 3,400 | — | $0 | 10,200 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2019-02-01 | 2019-02-05 | 3,400 | — | $0 | 142,843 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2019-02-01 | 2019-02-05 | 1,114 | $6.96 | $7.8K | 141,729 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2018-12-18 | 2018-12-21 | 1,625 | — | $0 | 1,625 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2018-12-18 | 2018-12-21 | 1,625 | — | $0 | 139,889 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2018-12-18 | 2018-12-21 | 446 | $6.30 | $2.8K | 139,443 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2018-12-15 | 2018-12-18 | 1,300 | — | $0 | 2,600 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2018-12-15 | 2018-12-18 | 357 | $7.31 | $2.6K | 138,264 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2018-12-15 | 2018-12-18 | 1,300 | — | $0 | 138,621 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2018-05-07 | 2018-05-09 | 5,200 | — | $0 | 3,900 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2018-05-07 | 2018-05-09 | 5,200 | — | $0 | 138,801 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2018-05-07 | 2018-05-09 | 1,480 | $18.10 | $26.8K | 137,321 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2018-02-01 | 2018-02-05 | 13,600 | — | $0 | 13,600 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2018-02-01 | 2018-02-05 | 47,600 | — | $0 | 47,600 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2017-12-18 | 2017-12-21 | 1,625 | — | $0 | 3,250 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2017-12-18 | 2017-12-21 | 494 | $24.12 | $11.9K | 133,601 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2017-12-18 | 2017-12-21 | 1,625 | — | $0 | 134,095 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2017-12-15 | 2017-12-21 | 1,300 | — | $0 | 9,100 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2017-12-15 | 2017-12-21 | 1,300 | — | $0 | 132,865 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2017-12-15 | 2017-12-21 | 395 | $24.23 | $9.6K | 132,470 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2016-12-18 | 2016-12-20 | 1,625 | — | $0 | 4,875 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2016-12-18 | 2016-12-20 | 494 | $31.25 | $15.4K | 131,565 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2016-12-18 | 2016-12-20 | 1,625 | — | $0 | 132,059 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2016-12-15 | 2016-12-19 | 10,400 | — | $0 | 10,400 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2016-12-15 | 2016-12-19 | 62,400 | — | $0 | 62,400 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2015-12-18 | 2015-12-22 | 58,516 | — | $0 | 58,516 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2015-12-18 | 2015-12-22 | 6,500 | — | $0 | 6,500 | SEC↗ |